FLESHNER NEIL E. 4
4 · POINT Biopharma Global Inc. · Filed Jul 8, 2021
Insider Transaction Report
Form 4
FLESHNER NEIL E.
DirectorChief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-07-06+25,000→ 25,000 totalExercise: $8.47Exp: 2027-07-06→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on July 6, 2022 with the remaining 75% vesting in three equal annual installments thereafter.